The RxEars Rxi is a budget-priced prescription hearing aid in an invisible-in-ear style, earning a B SoundGrade in HearAdvisor's lab testing. At $499, it represents one of the most affordable prescription options available, making professional-fitted amplification accessible to cost-conscious consumers.
In our testing, the Rxi demonstrated above-average speech intelligibility performance, scoring notably well in quiet listening environments (+0.49 points above the prescription category average) and holding its own in noisy situations (+0.18 above average). For users primarily concerned with conversational clarity, these results suggest solid core functionality despite the budget positioning.
However, the device shows meaningful limitations. Own-voice comfort scored well below the category average (-1.16 points), indicating that users may experience noticeable occlusion effects—that "plugged up" sensation when speaking. Additionally, the Rxi lacks music streaming capability entirely, which is increasingly standard even in lower-priced devices. Feedback handling performed slightly below average but remained acceptable at 4.70/5.
The RxEars Rxi is best suited for budget-minded individuals who prioritize speech clarity over connectivity features and can tolerate some own-voice occlusion. Those seeking streaming functionality or more natural own-voice perception should consider alternatives like the Elehear Beyond, which at $399 actually costs less while delivering a higher overall SoundScore of 4.35.
